您的购物车当前为空
别名 Firmonertinib, AST2818
Alflutinib (Firmonertinib) 是 EGFR 抑制剂。 它对 T790M 的性耐药突变以及 EGFR 活性突变具有抑制作用。它对于癌症疾病,特别是非小细胞肺癌(NSC-LC)方面具有研究潜力。

Alflutinib (Firmonertinib) 是 EGFR 抑制剂。 它对 T790M 的性耐药突变以及 EGFR 活性突变具有抑制作用。它对于癌症疾病,特别是非小细胞肺癌(NSC-LC)方面具有研究潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 662 | In Stock | |
| 5 mg | ¥ 1,060 | In Stock | |
| 10 mg | ¥ 1,590 | In Stock | |
| 25 mg | ¥ 2,750 | In Stock | |
| 50 mg | ¥ 4,120 | In Stock | |
| 100 mg | ¥ 5,870 | In Stock | |
| 200 mg | ¥ 7,890 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,320 | In Stock |
Alflutinib 相关产品
| 产品描述 | Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition. |
| 靶点活性 | EGFR:, CYP3A4:0.25 μM(EC50)(Cell-free assay) |
| 别名 | Firmonertinib, AST2818 |
| 分子量 | 568.59 |
| 分子式 | C28H31F3N8O2 |
| CAS No. | 1869057-83-9 |
| Smiles | CN1C=C(C=2C1=CC=CC2)C3=NC(NC4=C(OCC(F)(F)F)N=C(N(CCN(C)C)C)C(NC(C=C)=O)=C4)=NC=C3 |
| 密度 | 1.29 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 10.83 mg/mL (19.05 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容